Study of AZD0754 in Participants With Metastatic Prostate Cancer

Recruiting

Phase 1

Phase 2

Study of AZD0754 in Participants With Metastatic Prostate CancerStudy of AZD0754 in Participants With Metastatic Prostate Cancer

Sponsor:

AstraZeneca

Code:

NCT06267729

Conditions

Metastatic Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

AZD0754

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by AstraZeneca on 2025-03-25.